Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × Neuritis × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

OTHER 10 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2432 Carcinoma, Non-Small-Cell Lung 2019 Breast Neoplasms 1740 Neoplasm Metastasis 1037 Colorectal Neoplasms 1024 Prostatic Neoplasms 895 Melanoma 817 Multiple Myeloma 801 Ovarian Neoplasms 747 Recurrence 713 Leukemia, Myeloid, Acute 693 Pancreatic Neoplasms 626 Lung Neoplasms 620 Lymphoma, Non-Hodgkin 608 Lymphoma 568 Stomach Neoplasms 514 Carcinoma, Hepatocellular 481 Carcinoma, Renal Cell 461 Squamous Cell Carcinoma of Head and Neck 435 Leukemia, Lymphocytic, Chronic, B-Cell 417 Lymphoma, Follicular 391 Head and Neck Neoplasms 375 Glioblastoma 361 Advanced Solid Tumors 348 Lymphoma, Large B-Cell, Diffuse 343 Leukemia 335 Small Cell Lung Carcinoma 331 Triple Negative Breast Neoplasms 328 Uterine Cervical Neoplasms 304 Advanced Solid Tumor 300

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05291286 2025-01-27

RETRO

Bexion Pharmaceuticals, Inc.

Phase EARLY_PHASE1 Completed

Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡